Family · cognitive
Cortexin
Cortexin (bovine/porcine cerebral cortex polypeptide complex)
A low-molecular-weight polypeptide mixture extracted from the cerebral cortex of cattle or pigs, studied for neurotrophic and neuroprotective signalling; because it is a complex mixture rather than a single molecule, any proposed activity reflects the sum of many peptide interactions.
Registered and marketed as a neurological medicine in Russia and some post-Soviet states; the clinical and preclinical evidence base is mostly Russian, often open-label, with limited independent replication. Not approved by the FDA or EMA.
- Studied in brain ischemia and stroke recovery
- Researched for cognitive dysfunction in children
- Explored in various CNS and post-viral neurological conditions
Educational overview only — no dosing instructions in the public hub.
Animal-derived biological product; long-term and independent human safety data are limited, and sourcing/purity plus the absence of Western regulatory oversight are the main practical risks.
Third-party CoA (identity, purity + quantification) plus documented animal-tissue origin controls are the minimum verification for a biological extract.
Registered as a prescription drug in Russia and several post-Soviet countries; not approved for human use in the EU, UK, or US, where it is treated as research-use-only or unapproved.
Frequently asked questions
- What is Cortexin used for?
- Studied in brain ischemia and stroke recovery. Researched for cognitive dysfunction in children. Explored in various CNS and post-viral neurological conditions. Registered and marketed as a neurological medicine in Russia and some post-Soviet states; the clinical and preclinical evidence base is mostly Russian, often open-label, with limited independent replication. Not approved by the FDA or EMA.
- Is Cortexin legal in Europe?
- Registered as a prescription drug in Russia and several post-Soviet countries; not approved for human use in the EU, UK, or US, where it is treated as research-use-only or unapproved.
- What are the risks and side effects of Cortexin?
- Animal-derived biological product; long-term and independent human safety data are limited, and sourcing/purity plus the absence of Western regulatory oversight are the main practical risks.
- How is the quality of Cortexin assessed?
- Third-party CoA (identity, purity + quantification) plus documented animal-tissue origin controls are the minimum verification for a biological extract.